Skip to main content
Northwestern University

Ulara Therapeutics, LLC

Founded: 2016

Northwestern Inventor:
Richard Silverman
Weinberg College of Arts and Sciences
Department of Chemistry

Dimitri Krainc
Feinberg School of Medicine
Department of Neurology

Ulara Therapeutics is a biopharmaceutical company developing next-generation, recombinant enzyme therapies that are intended to possess superior biologic properties relative to existing products. Ulara leverages a proprietary platform for screening and designing small molecule, covalent activators that will enhance enzyme specific activity and stability. The company seeks to translate these enhancements into therapies with improved clinical benefits for patients. Lysosomal storage disorders with unmet needs represent the first therapeutic targets.

Back to top